Adding HLA DQA1 Unacceptable Antigen Equivalences Table Histocompatibility Committee June 6-7, 2016 Board of Directors Meeting 1
How does this proposal support the OPTN Strategic Plan? Primary Goal: Promote living donor and transplant recipient safety: Prevent matching candidates with incompatible donors and help avoid acute rejection, prolonged cold ischemia time, or organ discard Improve waitlisted patient, living donor, and transplant recipient outcomes: Reduces risk of rejection associated with HLA DQA1 mismatched donors Promote the efficient management of the OPTN: Aligns entry of DQA1 unacceptables with that for all other HLA loci for consistency in UNet SM 2
What problem will the proposal solve? Selecting broad value as unacceptable Doesn’t exclude donors with a subtype value, and candidates can match with donors if subtypes aren’t selected 3
How does the proposal solve the problem? Creates an additional HLA Equivalence table for DQA1 Allows UNOS IT to Selecting broad value accurately program as unacceptable DQA1 unacceptable antigens Will exclude donors with a subtype value. 4
Was this proposal changed in response to public comment? No substantive changes made post-public comment Stylistic changes for language consistency and ease of reading Non-discussion agenda at regional meetings 0 No votes ASHI, AST, & ASTS expressed support for the proposal as written 5
How will members implement this proposal? Members should familiarize themselves with changes in unacceptable antigen entry upon programming Histocompatibility labs may need to work with third party vendors to update reporting systems No new compliance requirements 6
How will the OPTN implement this proposal? This policy will be programmed by UNOS IT 7
Overall Project Impact Product Policy Impacted Histocompatibility Labs Populations: Transplant Coordinators Total IT Implementation 1,125/12,820 Hours Total Overall 1,380/19,560 Implementation and Maintenance Hours 8
Resolution 11 (page 47) RESOLVED, that changes to Policy 4.10 (Reference Tables of HLA Antigen Values and Split Equivalences), as set forth below, are hereby approved, effective pending programming and notice to OPTN members. 9
Recommend
More recommend